Independent AccuVein Study Shows 45 Percent Reduction in Escalations
Long Island, New York (August 4, 2014) – AccuVein Inc. (www.accuvein.com), the global leader in vein visualization, today announced the completion of a study by UF Health Shands Hospital, a U.S. News & World Report top-ranked children’s hospital. The study, which took place in six nursing units, evaluated the impact of AccuVein vein visualization on the number of times it was necessary to escalate a PIV start to central resource staff.
Study results showed a striking 45% reduction in escalation calls following the implementation of the AccuVein, with 91% of nurses reporting likelihood to use the device prior to escalating call. In addition, 81% of the nurses surveyed reported an improved ability to cannulate veins. The data from this analysis was displayed at the Infusion Nurses Society 2014 Annual Convention that took place in May and was included in the July/August issue of the Journal of Infusion Nursing.
“We are thrilled that such a drastic reduction in escalations was seen, as this translates to a significant time and cost savings for the hospital, said AccuVein Vice President Wayne Shepherd. “And most importantly patient care is improved when vein access procedures are streamlined and expedited.”
This study comes on the heels of the recommendation by the Infusion Nurses Society in their safety guidelines to incorporate vein visualization technology as a routine strategy. The INS stated, “visualization technology can improve success rates, decrease unsuccessful insertion attempts and improve patient satisfaction.”
To request a copy of the UF Health Shands Hospital Study, “Implementation of Near-Infrared Technology to Facilitate Successful PIV Cannulation”, please send an email to email@example.com.
About AccuVein Inc. AccuVein Inc. is a leader in medical imaging. AccuVein is the world’s only hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. AccuVein devices are in use at 3,000 hospitals and available for sale in over 100 countries worldwide. To see a demonstration of AccuVein vein illumination, please visit https://www.accuvein.com.